Cite

HARVARD Citation

    Hendriks, L. et al. (n.d.). 1408PPrognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI). Annals of oncology. p. . [Online]. 
  
Back to record